VMAT Reduces Moderate to High Integral Dose When Compared to Conventional IMRT for Treatment of Prostate Cancer

Organs-at-risk dose and normal tissue complication probability with dynamic trajectory radiotherapy (DTRT) for head and neck cancer

We compared dynamic trajectory radiotherapy (DTRT) to state-of-the-art volumetric modulated arc therapy (VMAT) for 46 head and neck cancer cases. DTRT had lower dose to salivary glands and swallowing structure, resulting in lower predicted xerostomia and dysphagia compared to VMAT. DTRT is deliverable on C-arm linacs with high dosimetric accuracy.

Mean Arc Distance (MAD): a quantity to compare trajectory 4πsampling in single target cranial stereotactic radiotherapy

Purpose:C-arm linac-based radiotherapy has seen a recent interest in 4 methods of delivery using simultaneous rotations of couch and gantry to reduce doses to organs-at-risk (OARs) and increase dose compactness. While many methods use heuristics to generate trajectories that avoid OARs, combined with arbitrary trajectory restrictions to prevent oversampling, a quantity has not yet been developed to succinctly compare sampling of the 4 space for candidate trajectories as a surrogate for dosimetric compactness.Methods:Evenly spaced sampling points were distributed across a 4 sphere centred on isocentre. A metric, mean arc distance (MAD), was defined that quantifies the average arc distance between all fields in a radiotherapy trajectory and their nearest sampling point. The relationship between isodose volume and MAD was examined in 2,047 plans: 900 unique trajectories of fixed port DCA plans, 900 unique trajectories of contiguous field DCA plans, 192 VMAT plans (eight volumes in four locations, each with six trajectories) in matRad with 5 VMAT plans repeated for validation in a clinical planning system, and 10 clinical VMAT cases replanned with five trajectories in a clinical treatment planning system.Results:All isodose volumes greater than 10 % of the prescription dose decreased with decreasing MAD in all comparisons. In the range of 10 % to 100 % of the prescription dose, the rate of isodose volume decrease was exponential as a function of MAD in all comparisons. Reduction of absolute isodose volume is seen with increased 4 sampling, with larger target volumes exhibiting larger absolute reductions. Very low isodoses (0 % to 10 % of prescription) increased with decreasing MAD.Conclusions:MAD is a 4 sampling quantity useful in quantifying the decrease of isodose volume, relevant for sparing normal tissues. By quantifying this feature, candidate dynamic trajectories can be efficiently compared for 4 sampling. This quantity is explored here for single target cranial radiotherapy but may have applications to other radiotherapy treatment site.